BACKGROUND/AIMS: Metabolic syndrome may increase the risk for incident cardiovascular disease (CVD) and all-cause mortality in the general population. It is unclear whether, and to what degree, metabolic syndrome is associated with CVD in chronic kidney disease (CKD). We determined metabolic syndrome prevalence among individuals with a broad spectrum of kidney dysfunction, examining the role of the individual elements of metabolic syndrome and their relationship to prevalent CVD. METHODS: We evaluated four models to compare metabolic syndrome or its components to predict prevalent CVD using prevalence ratios in the Chronic Renal Insufficiency Cohort (CRIC) Study. RESULTS: Among 3,939 CKD participants, the prevalence of metabolic syndrome was 65% and there was a significant association with prevalent CVD. Metabolic syndrome was more common in diabetics (87.5%) compared with non-diabetics (44.3%). Hypertension was the most prevalent component, and increased triglycerides the least prevalent. Using the bayesian information criterion, we found that the factors defining metabolic syndrome, considered as a single interval-scaled variable, was the best of four models of metabolic syndrome, both for CKD participants overall and for diabetics and non-diabetics separately. CONCLUSION: The predictive value of this model for future CVD outcomes will subsequently be validated in longitudinal analyses.
BACKGROUND/AIMS: Metabolic syndrome may increase the risk for incident cardiovascular disease (CVD) and all-cause mortality in the general population. It is unclear whether, and to what degree, metabolic syndrome is associated with CVD in chronic kidney disease (CKD). We determined metabolic syndrome prevalence among individuals with a broad spectrum of kidney dysfunction, examining the role of the individual elements of metabolic syndrome and their relationship to prevalent CVD. METHODS: We evaluated four models to compare metabolic syndrome or its components to predict prevalent CVD using prevalence ratios in the Chronic Renal Insufficiency Cohort (CRIC) Study. RESULTS: Among 3,939 CKD participants, the prevalence of metabolic syndrome was 65% and there was a significant association with prevalent CVD. Metabolic syndrome was more common in diabetics (87.5%) compared with non-diabetics (44.3%). Hypertension was the most prevalent component, and increased triglycerides the least prevalent. Using the bayesian information criterion, we found that the factors defining metabolic syndrome, considered as a single interval-scaled variable, was the best of four models of metabolic syndrome, both for CKD participants overall and for diabetics and non-diabetics separately. CONCLUSION: The predictive value of this model for future CVD outcomes will subsequently be validated in longitudinal analyses.
Authors: Apoor S Gami; Brandi J Witt; Daniel E Howard; Patricia J Erwin; Lisa A Gami; Virend K Somers; Victor M Montori Journal: J Am Coll Cardiol Date: 2007-01-12 Impact factor: 24.094
Authors: Michael G Shlipak; Ronit Katz; Mark J Sarnak; Linda F Fried; Anne B Newman; Catherine Stehman-Breen; Stephen L Seliger; Brian Kestenbaum; Bruce Psaty; Russell P Tracy; David S Siscovick Journal: Ann Intern Med Date: 2006-08-15 Impact factor: 25.391
Authors: Todd S Perlstein; Marie Gerhard-Herman; Norman K Hollenberg; Gordon H Williams; Abraham Thomas Journal: J Am Soc Nephrol Date: 2007-02-07 Impact factor: 10.121
Authors: Janice Lea; Deanna Cheek; Denise Thornley-Brown; Lawrence Appel; Lawrence Agodoa; Gabriel Contreras; Jennifer Gassman; Jim Lash; Edgar R Miller; Otelio Randall; Xuelei Wang; William McClellan Journal: Am J Kidney Dis Date: 2008-03-20 Impact factor: 8.860
Authors: Alain G Bertoni; Nathan D Wong; Steven Shea; Shuangge Ma; Kiang Liu; Srikanthan Preethi; David R Jacobs; Colin Wu; Mohammed F Saad; Moyses Szklo Journal: Diabetes Care Date: 2007-08-17 Impact factor: 19.112
Authors: Kathleen D Liu; Wei Yang; Alan S Go; Amanda H Anderson; Harold I Feldman; Michael J Fischer; Jiang He; Radhakrishna R Kallem; John W Kusek; Stephen R Master; Edgar R Miller; Sylvia E Rosas; Susan Steigerwalt; Kaixiang Tao; Matthew R Weir; Chi-Yuan Hsu Journal: Am J Kidney Dis Date: 2014-10-11 Impact factor: 8.860
Authors: Jayanta Gupta; Nandita Mitra; Raymond R Townsend; Michael Fischer; Jeffrey R Schelling; David J Margolis Journal: Wound Repair Regen Date: 2016-06-20 Impact factor: 3.617
Authors: Sankar D Navaneethan; Jesse D Schold; John P Kirwan; Susana Arrigain; Stacey E Jolly; Emilio D Poggio; Srinivasan Beddhu; Joseph V Nally Journal: Clin J Am Soc Nephrol Date: 2013-02-14 Impact factor: 8.237
Authors: Rachana Shah; Gregory J Matthews; Rhia Y Shah; Catherine McLaughlin; Jing Chen; Melanie Wolman; Stephen R Master; Boyang Chai; Dawei Xie; Daniel J Rader; Dominic S Raj; Nehal N Mehta; Matthew Budoff; Michael J Fischer; Alan S Go; Raymond R Townsend; Jiang He; John W Kusek; Harold I Feldman; Andrea S Foulkes; Muredach P Reilly Journal: Am J Kidney Dis Date: 2015-03-17 Impact factor: 8.860
Authors: Meyeon Park; Chi-Yuan Hsu; Alan S Go; Harold I Feldman; Dawei Xie; Xiaoming Zhang; Theodore Mifflin; Sushrut S Waikar; Venkata S Sabbisetti; Joseph V Bonventre; Josef Coresh; Robert G Nelson; Paul L Kimmel; John W Kusek; Mahboob Rahman; Jeffrey R Schelling; Ramachandran S Vasan; Kathleen D Liu Journal: Clin J Am Soc Nephrol Date: 2017-03-02 Impact factor: 8.237
Authors: David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra Journal: Wound Repair Regen Date: 2012-12-10 Impact factor: 3.617
Authors: Jordana B Cohen; Alisa J Stephens-Shields; Michelle R Denburg; Amanda H Anderson; Raymond R Townsend; Peter P Reese Journal: Am J Nephrol Date: 2016-05-28 Impact factor: 3.754